Business Description
PhytoHealth Corp
ISIN : TW0004108006
Total Employee Number:
84Description
PhytoHealth Corp engages in the research and development, production, manufacture, and sale of pharmaceutical drugs, cosmetics, Class B drugs, and dietary supplements. The company's product portfolio comprises White Blood Crystals Injection, White Pain Relief Soft Capsules, WhiteGilead, and White AminoSpeed supplements. Additionally, it is developing PHN031 (White Bone) for the prevention of osteoporosis; PHN033 (White Sugar) for the treatment of diabetic nephropathy; PHN016 for cancer treatment; and PHN017 for the treatment of cytokine storm. The company's reportable operating segments are: Pharmaceutical drugs and dietary supplement, which generate maximum revenue, Medical diagnostic products, and Precision medical equipment. Geographically, it derives maximum revenue from Taiwan.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 68.08 | |||||
Equity-to-Asset | 0.8 | |||||
Debt-to-Equity | 0.01 | |||||
Debt-to-EBITDA | -0.26 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 25.12 | |||||
Beneish M-Score | -2.38 | |||||
WACC vs ROIC | ||||||
Growth Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -0.2 | |||||
3-Year EBITDA Growth Rate | 0.8 | |||||
3-Year EPS without NRI Growth Rate | 10.2 | |||||
3-Year FCF Growth Rate | 9.5 | |||||
3-Year Book Growth Rate | -0.6 |
Momentum Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 37.97 | |||||
9-Day RSI | 43.78 | |||||
14-Day RSI | 45.74 | |||||
3-1 Month Momentum % | -1.2 | |||||
6-1 Month Momentum % | -11.43 | |||||
12-1 Month Momentum % | -6.77 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 27.41 | |||||
Quick Ratio | 24.67 | |||||
Cash Ratio | 23.22 | |||||
Days Inventory | 556.35 | |||||
Days Sales Outstanding | 104.67 | |||||
Days Payable | 21.01 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Shareholder Yield % | 0.11 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 30.68 | |||||
Operating Margin % | -129.73 | |||||
Net Margin % | -43.25 | |||||
EBITDA Margin % | -45.08 | |||||
FCF Margin % | -33.87 | |||||
OCF Margin % | -29.51 | |||||
ROE % | -3.11 | |||||
ROA % | -2.45 | |||||
ROIC % | -15.11 | |||||
3-Year ROIIC % | -6.17 | |||||
ROC (Joel Greenblatt) % | -29.15 | |||||
ROCE % | -4.72 |
GF Value Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Price-to-Owner-Earnings | 411.67 | |||||
PS Ratio | 18.58 | |||||
PB Ratio | 1.27 | |||||
Price-to-Tangible-Book | 1.31 | |||||
EV-to-EBIT | -15.94 | |||||
EV-to-EBITDA | -28.83 | |||||
EV-to-Revenue | 13 | |||||
EV-to-FCF | -39.9 | |||||
Price-to-GF-Value | 0.75 | |||||
Price-to-Projected-FCF | 3.21 | |||||
Price-to-Median-PS-Value | 0.61 | |||||
| Price-to-Net-Current-Asset-Value | 3.04 | |||||
| Price-to-Net-Cash | 4.04 | |||||
Earnings Yield (Greenblatt) % | -6.28 | |||||
FCF Yield % | -1.92 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
PhytoHealth Corp Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil NT$) | 134.576 | ||
| EPS (TTM) (NT$) | -0.286 | ||
| Beta | 0.1591 | ||
| 3-Year Sharpe Ratio | -1.06 | ||
| 3-Year Sortino Ratio | -1.27 | ||
| Volatility % | 23.15 | ||
| 14-Day RSI | 45.74 | ||
| 14-Day ATR (NT$) | 0.33853 | ||
| 20-Day SMA (NT$) | 12.1025 | ||
| 12-1 Month Momentum % | -6.77 | ||
| 52-Week Range (NT$) | 11.4 - 17.9 | ||
| Shares Outstanding (Mil) | 198.62 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
PhytoHealth Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
PhytoHealth Corp Stock Events
| Event | Date | Price (NT$) | ||
|---|---|---|---|---|
| No Event Data | ||||
PhytoHealth Corp Frequently Asked Questions
What is PhytoHealth Corp(TPE:4108)'s stock price today?
The current price of TPE:4108 is NT$12.00. The 52 week high of TPE:4108 is NT$17.90 and 52 week low is NT$11.40.
When is next earnings date of PhytoHealth Corp(TPE:4108)?
The next earnings date of PhytoHealth Corp(TPE:4108) is .
Does PhytoHealth Corp(TPE:4108) pay dividends? If so, how much?
PhytoHealth Corp(TPE:4108) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on PhytoHealth Corp
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers